OR WAIT null SECS
Jennifer K. Priessnitz, MD, a resident at Macon & Joan Brock Virginia Health Sciences at Old Dominion University.
November 18, 2026
Article
At ACAAI 2026, Jennifer Priessnitz, MD presented data which found omalizumab had the highest anaphylaxis reporting proportion among 7 respiratory biologics.